Tracking epithelial-mesenchymal transition in breast cancer cells based on a multiplex electrochemical immunosensor
Biosensors and Bioelectronics · 2024-08 · 258 · 116372
DOI: 10.1016/j.bios.2024.116372 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2024-08. Verfasst von Xue Wei und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Chemical Resource Engineering, Beijing University of Chemical Technology, Beijing, 100029, PR China. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Biosensing Techniques, Breast Neoplasms, Gold. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Epithelial-mesenchymal transition (EMT) promotes tumor cell infiltration and metastasis. Tracking the progression of EMT could potentially indicate early cancer metastasis. A key characteristic of EMT is the dynamic alteration in the molecular levels of E-cadherin and N-cadherin. Traditional assays have limited sensitivity and multiplexing capabilities, relying heavily on cell lysis. Here, we developed a multiplex electrochemical biosensor to concurrently track the upregulation of N-cadherin expression and reduction of E-cadherin in breast cancer cells undergoing EMT. Small-sized gold nanoparticles (Au NPs) tagged with redox probes (thionin or amino ferrocene) and bound to two types of antibodies were used as distinguishable signal tags. These tags specifically recognized E-cadherin and N-cadherin proteins on the tumor cell surface without cross-reactivity. The diphenylalanine dipeptide (FF)/chitosan (CS)/Au NPs (FF-CS@Au) composites with high surface area and good biocompatibility were used as the sensing platforms for efficiently fixing cells and recording the dynamic changes in electrochemical signals of surface proteins. The electrochemical immunosensor allowed for simultaneous monitoring of E- and N-cadherins on breast cancer cell surfaces in a single run, enabling tracking of the EMT dynamic process for up to 60 h. Furthermore, the electrochemical detection results are consistent with Western blot analysis, confirming the reliability of the methodology. This present work provides an effective, rapid, and low-cost approach for tracking the EMT process, as well as valuable insights into early tumor metastasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Chemical Resource Engineering, Beijing University of Chemical Technology, Beijing, 100029, PR China.
- State Key Laboratory of Chemical Resource Engineering, Beijing University of Chemical Technology, Beijing, 100029, PR China. Electronic address: chenxu@mail.buct.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wei, X., Xiong, H., Zhou, Y., Chen, X., & Yang, W. (2024). Tracking epithelial-mesenchymal transition in breast cancer cells based on a multiplex electrochemical immunosensor. Biosensors and Bioelectronics, 258, 116372. https://doi.org/10.1016/j.bios.2024.116372
Vancouver
Wei X, Xiong H, Zhou Y, Chen X, Yang W. Tracking epithelial-mesenchymal transition in breast cancer cells based on a multiplex electrochemical immunosensor. Biosensors and Bioelectronics. 2024;258:116372. doi:10.1016/j.bios.2024.116372
BibTeX
@article{Wei2024,
author = {Wei, Xue and Xiong, Hanzhi and Zhou, Yunfan and Chen, Xu and Yang, Wensheng},
title = {Tracking epithelial-mesenchymal transition in breast cancer cells based on a multiplex electrochemical immunosensor},
journal = {Biosensors and Bioelectronics},
year = {2024},
volume = {258},
pages = {116372},
doi = {10.1016/j.bios.2024.116372}
}
EUVIMED